| Literature DB >> 29496992 |
Vani G S Narasimhulu1,2, Anna K Bellamy-McIntyre1,3, Annamarie E Laumaea1,2, Chan-Sien Lay4, David N Harrison1, Hannah A D King1,2, Heidi E Drummer1,2,3, Pantelis Poumbourios5,3,4.
Abstract
HIV-1 is spread by cell-free virions and by cell-cell viral transfer. We asked whether the structure and function of a broad neutralizing antibody (bNAb) epitope, the membrane-proximal ectodomain region (MPER) of the viral gp41 transmembrane glycoprotein, differ in cell-free and cell-cell-transmitted viruses and whether this difference could be related to Ab neutralization sensitivity. Whereas cell-free viruses bearing W666A and I675A substitutions in the MPER lacked infectivity, cell-associated mutant viruses were able to initiate robust spreading infection. Infectivity was restored to cell-free viruses by additional substitutions in the cytoplasmic tail (CT) of gp41 known to disrupt interactions with the viral matrix protein. We observed contrasting effects on cell-free virus infectivity when W666A was introduced to two transmitted/founder isolates, but both mutants could still mediate cell-cell spread. Domain swapping indicated that the disparate W666A phenotypes of the cell-free transmitted/founder viruses are controlled by sequences in variable regions 1, 2, and 4 of gp120. The sequential passaging of an MPER mutant (W672A) in peripheral blood mononuclear cells enabled selection of viral revertants with loss-of-glycan suppressor mutations in variable region 1, suggesting a functional interaction between variable region 1 and the MPER. An MPER-directed bNAb neutralized cell-free virus but not cell-cell viral spread. Our results suggest that the MPER of cell-cell-transmitted virions has a malleable structure that tolerates mutagenic disruption but is not accessible to bNAbs. In cell-free virions, interactions mediated by the CT impose an alternative MPER structure that is less tolerant of mutagenic alteration and is efficiently targeted by bNAbs.Entities:
Keywords: cell–cell transmission; glycoprotein; human immunodeficiency virus (HIV); membrane fusion; mutant; neutralization; viral replication; virus entry
Mesh:
Substances:
Year: 2018 PMID: 29496992 PMCID: PMC5912456 DOI: 10.1074/jbc.RA117.000537
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157